Search

Two new therapy options have demonstrated significant advances in survival outcomes for select patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. Both studies were presented today at the 2025 ASCO Annual Meeting in Chicago and simultaneously published in The New England Journal of Medicine.

… Saturday, May 31, 2025 Two new therapy options have demonstrated significant advances in survival outcomes for select patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. Both studies were presented today at the 2025 ASCO Annual

New MSK research identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.

… Wednesday, April 23, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife

A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.

… Tuesday, June 1, 2010 Summary A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness. It has long been known that circulating tumor cells (CTCs) — cells that have broken away from a

If you think women are the only people who get cancers caused by the human papillomavirus (HPV), think again. These cancers are on the rise in men.

… Thursday, June 10, 2021 Rich Delgrosso found the lump while shaving. It was on the left side of his neck and it seemed to grow bigger by the day. He made an appointment with his ear, nose, and throat doctor. “He said the odds were 50/50 that it was an infection,” recalls the 56-year-old father of two

Dr. Mao leads a team of integrative medicine specialists who offer complementary therapies such as massage and acupuncture to patients and caregivers.

… Friday, November 11, 2016 Summary As Chief of the Integrative Medicine Service at MSK, Jun Mao oversees a unique offering of services for patients, including acupuncture , music and dance therapy, nutrition counseling , and more. Jun Mao recently joined MSK as Chief of the Integrative Medicine Service

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal residual disease (MRD) responses compared to VRd alone in patients with newly diagnosed, transplant-ineligible multiple myeloma.

… Monday, February 17, 2025 UPDATE January 27, 2026: The U.S. Food and Drug Administration (FDA)  approved  the quadruplet therapy daratamumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of adult patients with newly

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib.

… Wednesday, November 23, 2011 Research led by investigators at Memorial Sloan Kettering Cancer Center has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib, an oral targeted therapy used to treat advanced melanoma whose tumors contain a mutation in

Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.

… Monday, January 6, 2014 Summary Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer. Memorial Sloan Kettering is one of six elite academic institutions to share an unprecedented total of $540 million

A multidisciplinary team at Memorial Sloan Kettering Cancer Center (MSK) has developed a proof-of-concept crisis ventilator intended to provide lifesaving breathing assistance to patients requiring it when more-sophisticated respiratory support equipment is unavailable.

… Thursday, April 23, 2020 VIDEO | 00:00:12 Crisis Vent Video Details A multidisciplinary team at Memorial Sloan Kettering Cancer Center (MSK) has developed a proof-of-concept crisis ventilator intended to provide lifesaving breathing assistance to patients requiring it when more-sophisticated respiratory

GSK students, alumni, faculty, and guest speakers enjoyed two days of presentations, panel discussions, a poster session, recreation and socializing at the school’s fourth biennial retreat.

… Monday, June 6, 2016 MSK President and CEO Craig Thompson MSK President and CEO Craig Thompson gives a talk at the retreat about his work in cancer metabolism. GSK alumnus John Maciejowkski talks with GSK Dean Ken Marians and Charles Rudin GSK alumnus John Maciejowkski talks with GSK Dean Ken Marians